Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Can this be confirmed?

At the latest shareholder meeting, did not the BoD say that future revenue would be distributed in the form of dividends instead of M&A activity? Was that my wishful thinking or someone here saying dividends and than I attached it to BoD?

I thought there was discussion of dividends at shareholder meeting. If so, why has that topic gone so silent?

Share
New Message
Please login to post a reply